Tecarfarin Anti-Coagulation Trial (TACT)

Clinical trial NCT02522221 · UNKNOWN

Trial details

NCT number: NCT02522221
Sponsor: Espero Biopharma
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Thromboembolism Thrombosis

Start date: 2018-06-01
Primary completion: 2019-03-30
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.